MediConnect

MediConnect

ICO Ended
12,892 Views
MediConnect is the only blockchain solution intended to revolutionize the use of medication in the UK. It will prevent the over-prescribing to patients of medication from multiple pharmacies, reduce addiction, provide traceability of drugs from manufacturers, wholesalers, prescribers and pharmacies all the way through to patients. This will enable the removal of false medicines and the easy recall of drugs within the Pharma system.

The Safety Net for Patients, Prescribers, Pharmacies and Drug Manufacturers:

With all the regulatory bodies within the Pharmacy sector recognizing and concerned about the growing issue of over-prescribing of prescription medication online, MediConnect can offer a solution to this growing problem almost immediately.

Prescribers & pharmacies using MediConnect will have the confidence that by using our blockchain solution, the misuse and over-prescribing of prescription medication to potential addicts – who would normally shop around online for medication – will be eliminated.

Patients will be given the assurance that the medication they are being prescribed is genuine and from a licensed manufacturer, prescriber and pharmacy that is using a gold-standard solution to help improve their own duty of care.
7.0
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

3
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 06 Feb 2019 - 16 Feb 2019
ICO Time: 20 Feb 2019 - 30 Sept 2019
Whitelist/KYC: Whitelist + KYC
Country: UK
Token info
Ticker: MEDI
Platform: Stratis
Token Type: Utility
Available for sale: 335,000,000 MEDI (67%)
Total supply: 500,000,000 MEDI
Financial
Raised $ 846,984
ICO Price: 1 MEDI = 0.02 USD
Accepting: STRAT, BTC
Hard cap: 10,000,000 USD
Q1 2018
Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.
Q2 2018
Agreed blockchain platform partnership with Stratis.
Q3 2018
Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.
Q4 2018
Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.<br /> <br /> <br /> Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.<br /> <br /> <br /> Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.
Q1 2019
ICO Public Sale.<br /> <br /> <br /> PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
Q2 2019
Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.<br /> <br /> <br /> Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.<br /> <br /> <br /> 6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.
Q3 2019
Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.<br /> <br /> <br /> Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.
Q4 2019
Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.
Q1 2020
The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.
Q2 2020
Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.
Q3 2020
Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.
Q4 2020
The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies
Screenshots taken on 25 Jan 2019
Dexter Blackstock
Director
Participates in a number of projects
Bobby Cato
Operational Manager
Participates in a number of projects
Harry Chathli
Head of Investor Relations, Communications and Strategy
Participates in a number of projects
Gary Nelson
Head of Engineering
Participates in a number of projects

Advisors (5)

Samuel Ogunsalu
Participates in a number of projects
Shyam Morjaria
Participates in a number of projects
Patrick Curry OBE
Participates in a number of projects
Joe Soiza
Participates in a number of projects
Chris Trew
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
DINO
In blockchain world, there is a huge knowledge gulf between non-computer professionals from different industries and smart contract development. The DINO Platform aims to address this problem with its proprietary technology, a cloud-based Graphical User Interface (GUI) smart contract Integrated Development Environment (IDE). Leveraging the technology of the DINO Platform, users can build their smart contracts with visualised logic flows. More than just a smart contract IDE, the DINO Platform is intended to build a smart contract ecosystem together with developers all over the world. In the smart contract market, developers may build and design smart contract templates and sell them to the general public.
Upcoming
GoRecruit
GoRecruit is an AI recruitment system based on blockchain technology, which offers a new way of evaluating job applicants. The AI system, being a convenient online service, enables making HR decisions based on the analysis of data from social networks and publicly available sources. To select applicants for an interview, one does not need to spend several hours for processing and analyzing the data: one will acquire the detailed information with recommendations immediately after the authorization of a candidate in the GoRecruit system. This approach will make access to vacancies more open, eliminate human error in hiring, as well as reduce the cost of HR service by optimizing routine work.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.